메뉴 건너뛰기




Volumn 36, Issue 4, 2009, Pages 854-

What rheumatologists should know about gout and cardiovascular disease

Author keywords

[No Author keywords available]

Indexed keywords

URATE; URIC ACID;

EID: 66149128809     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.081039     Document Type: Letter
Times cited : (4)

References (10)
  • 1
    • 44349181594 scopus 로고    scopus 로고
    • Asymptomatic hyperuricemia: Perhaps not so benign? [editorial]
    • Neogi T. Asymptomatic hyperuricemia: Perhaps not so benign? [editorial]. J Rheumatol 2008;35:734-7.
    • (2008) J Rheumatol , vol.35 , pp. 734-737
    • Neogi, T.1
  • 2
    • 39749157632 scopus 로고    scopus 로고
    • Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: A preventive cardiology information system (PreCIS) database cohort study
    • Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum 2008;58:623-30.
    • (2008) Arthritis Rheum , vol.58 , pp. 623-630
    • Ioachimescu, A.G.1    Brennan, D.M.2    Hoar, B.M.3    Hazen, S.L.4    Hoogwerf, B.J.5
  • 3
    • 34548142983 scopus 로고    scopus 로고
    • Independent impact of gout on mortality and risk for coronary heart disease
    • Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007;116:894-900.
    • (2007) Circulation , vol.116 , pp. 894-900
    • Choi, H.K.1    Curhan, G.2
  • 4
    • 33748477254 scopus 로고    scopus 로고
    • Elevated serum uric acid levels in metabolic syndrome: An active component or an innocent bystander?
    • Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism 2006;55:1293-301.
    • (2006) Metabolism , vol.55 , pp. 1293-1301
    • Tsouli, S.G.1    Liberopoulos, E.N.2    Mikhailidis, D.P.3    Athyros, V.G.4    Elisaf, M.S.5
  • 5
    • 35948992181 scopus 로고    scopus 로고
    • Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome
    • Hjortnaes J, Algra A, Olijhoek J, et al. Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome. J Rheumatol 2007;34:1882-7.
    • (2007) J Rheumatol , vol.34 , pp. 1882-1887
    • Hjortnaes, J.1    Algra, A.2    Olijhoek, J.3
  • 6
    • 33750374233 scopus 로고    scopus 로고
    • EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
    • Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006;65:1301-11.
    • (2006) Ann Rheum Dis , vol.65 , pp. 1301-1311
    • Zhang, W.1    Doherty, M.2    Pascual, E.3
  • 7
    • 39549108111 scopus 로고    scopus 로고
    • In addition to insulin resistance and obesity, hyperuricemia is strongly associated with metabolic syndrome using different definitions in Chinese populations: A population-based study (Taichung Community Health Study)
    • Lin WY, Liu CS, Li TC, Cren CC, Li CI, Lin CC. In addition to insulin resistance and obesity, hyperuricemia is strongly associated with metabolic syndrome using different definitions in Chinese populations: a population-based study (Taichung Community Health Study). Ann Rheum Dis 2008;67:432-3.
    • (2008) Ann Rheum Dis , vol.67 , pp. 432-433
    • Lin, W.Y.1    Liu, C.S.2    Li, T.C.3    Cren, C.C.4    Li, C.I.5    Lin, C.C.6
  • 8
    • 38149095747 scopus 로고    scopus 로고
    • Are there specific treatments for the metabolic syndrome?
    • Giugliano D, Ceriello A, Esposito K. Are there specific treatments for the metabolic syndrome? Am J Clin Nutr 2008;87:8-11.
    • (2008) Am J Clin Nutr , vol.87 , pp. 8-11
    • Giugliano, D.1    Ceriello, A.2    Esposito, K.3
  • 9
    • 23244462442 scopus 로고    scopus 로고
    • Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us?
    • Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005;118:816-26.
    • (2005) Am J Med , vol.118 , pp. 816-826
    • Baker, J.F.1    Krishnan, E.2    Chen, L.3    Schumacher, H.R.4
  • 10
    • 34447514239 scopus 로고    scopus 로고
    • Uric acid and oxidative stress: Relative impact on cardiovascular risk?
    • Strazzullo P, Puig JG. Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutr Metab Cardiovasc Dis 2007;17:409-17.
    • (2007) Nutr Metab Cardiovasc Dis , vol.17 , pp. 409-417
    • Strazzullo, P.1    Puig, J.G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.